BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
Lobbying for BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
HR 1968, FY2025 Full-Year Continuing Appropriations and Extensions Act; HConRes 14, Concurrent Resolution on the Budget FY2025; Potential legislation funding the Department of Defense for FY26
HR 379, Healthcare Freedom and Choice Act; HR 483, Health Care Efficiency through Flexibility Act; HR 1509/S 752, Accelerating Kids' Access to Care Act; HR 1262/S 932, Give Kids a Chance Act; HR 2528, Association Health Plans Act; Draft legislation related to promoting investment in pediatric cancer drug development; Draft legislation related to promoting access to clinical trials; Pharmacy Benefit Manager reforms; Anti-competitive contracting reforms; CFPB medical debt regulations;
Preventing federal funding and benefit cuts to Medicaid; Site-neutral payment reforms in Medicaid;
Preventing Executive Branch rescissions and suspensions of NIH grants/grant funds; Education re the importance of staff roles within health agencies
HR 247/S 46, the Health Care Affordability Act; HR 801/S 317, Charitable Act